These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 4736825

  • 1. Phytohaemagglutinin-induced cytotoxic effector lymphocyte function in patients with the Wiskott-Aldrich syndrome (WAS).
    Sherwood G, Blaese RM.
    Clin Exp Immunol; 1973 Apr; 13(4):515-20. PubMed ID: 4736825
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Defective lymphocyte transformation and delayed hypersensitivity in Wiskott-Aldrich syndrome.
    Oppenheim JJ, Blaese RM, Waldmann TA.
    J Immunol; 1970 Apr; 104(4):835-44. PubMed ID: 4986478
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The detection and identification of subpopulations of circulating human lymphocytes, monocytes and neutrophils capable of effecting a mitogen-induced cell-mediated cytotoxic reaction towards erythrocytes of various species.
    Cortens M, Sklar S, Richter M.
    Immunology; 1980 Nov; 41(3):623-34. PubMed ID: 7461704
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The in vitro response of peripheral blood lymphocytes from patients with Wiskott-Aldrich syndrome.
    Marinkovich VA.
    Clin Allergy; 1972 Mar; 2(1):69-78. PubMed ID: 4275189
    [No Abstract] [Full Text] [Related]

  • 11. Disorders of regulatory T cell function in patients with the Wiskott-Aldrich syndrome.
    Zabay JM, Fontán G, Campos A, García-Rodriguez MC, Pascual-Salcedo D, Bootello A, de la Concha EG.
    Clin Exp Immunol; 1984 Apr; 56(1):23-8. PubMed ID: 6609033
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Transfer factor and thymosin in the treatment of Wiskott-Aldrich syndrome].
    Franchi F, Segni G, Stabile A, Ammirati P, Aiuti F.
    Minerva Pediatr; 1978 Apr 30; 30(8):609-13. PubMed ID: 661768
    [No Abstract] [Full Text] [Related]

  • 14. Diminished in vitro toxic effect of phytohaemagglutinin for lymphocytes of rats bearing syngeneic tumours.
    Medzihradský J, Babusíková O, Koníková E.
    Neoplasma; 1973 Apr 30; 20(4):353-61. PubMed ID: 4147074
    [No Abstract] [Full Text] [Related]

  • 15. Low level immunoglobulin production by mitogenically stimulated rabbit lymphocytes.
    Itatani CA, Fung HC.
    J Reticuloendothel Soc; 1974 Mar 30; 15(3):171-84. PubMed ID: 4838129
    [No Abstract] [Full Text] [Related]

  • 16. [Some immunohematological aspects of 2 cases of the Wiskott-Aldrich syndrome].
    Ferrara M, Ponte G, Esposito L.
    Pediatria (Napoli); 1983 Mar 30; 91(1):75-80. PubMed ID: 6604260
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cytotoxic lymphocytes in Hashimoto thyroiditis. An in vitro assay system using 51 Cr-labelled chicken red blood cells coated with thyroglobulin.
    Calder BA, Penhale WJ, Barnes EW, Irvine WJ.
    Clin Exp Immunol; 1973 May 30; 14(1):19-23. PubMed ID: 4740396
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Specificity of destruction by lymphocytes activated in mixed leukocyte culture.
    Lightbody JJ, Bach FH.
    Transplant Proc; 1972 Sep 30; 4(3):307-10. PubMed ID: 4263510
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.